drugset / Trial / NCT00119704
Treatment of Tennis Elbow With Botulinum Toxin
Phase 3
Completed
60 enrolled
Chinese University of Hong Kong
New World Development Company Limited · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine whether Botulinum A toxin is effective in the treatment of tennis elbow (lateral epicondylitis).
Timeline
- Start
- 2002-09
- Primary completion
- —
- Completion
- 2005-03
Outcome
Met primary endpoint
paper Mean VAS scores for the botulinum group at baseline and at 4 weeks were 65.5 mm and 25.3 mm, respectively; respective scores for the placebo group were 66.2 mm and 50.5 mm PMID 16330790 ↗
paper between-group difference of changes, 24.4 mm [95% CI, 13.0 to 35.8 mm]; P < 0.001 PMID 16330790 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 60 iu | Other |